JBT Marel
JBTM
104.33
-4.36
-4.01%
JBT Marel
US · JBTM
#1997 by market cap
Listed 1970
104.33
-4.36
-4.01%
Live - 5344 symbols - heartbeat 461s ago
· 2026-10-08 07:39
Pre-market
103.70
-0.60%
After-hours
104.40
+0.07%
- Market cap
- 5.41B
- P/E (TTM)i
- 28.27
- P/Bi
- 1.21
- EPSi
- -0.98
- Div yieldi
- 0.38%
- 52W posi
- 1%
Reader sentiment
Are you bullish or bearish on JBTM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 5 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.2 percentage points.
Institutional ownership
- Held by institutions
- 106.47% -0.15pp
- Institutions
- 458 -5
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund90.29%
Corporate Pension Plan5.15%
Hedge Fund3.72%
Public Company2.31%
Government Pension Fund1.54%
Sovereign Wealth Fund1.33%
Individual/Insider1.00%
Private Company0.88%
VC/PE Fund0.55%
Top holders as of 2026-06-30
BlackRock
15.35% · 7.93M sh
T. Rowe Price Group, Inc.
9.62% · 4.97M sh
Vanguard Portfolio Management, LLC
5.57% · 2.88M sh
Vanguard Capital Management, LLC
5.21% · 2.69M sh
UBS Asset Management
4.74% · 2.45M sh
State Street Global Advisors
4.09% · 2.12M sh
Lífeyrissjóilur Verzlunarmanna, Kt.
3.09% · 1.60M sh
Geode Capital Management, LLC
2.66% · 1.38M sh
Invesco Ltd.
2.59% · 1.34M sh
Gildi - lífeyrissjódur
2.07% · 1.07M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 19 buys · 29 sells
| Name | Role | Stake |
|---|---|---|
| Olafur Gudmundsson | Director | 0.23% |
| Brian Deck | Chief Executive Officer | 0.22% |
| Polly Kawalek | Independent Director | 0.15% |
| Alan Feldman | Independent Non-Executive Chairperson | 0.13% |
| Arni Sigurdsson | President | 0.04% |
| James Marvin | Executive VP, General Counsel & Assistant Secretary | 0.03% |
| Matthew Meister | Chief Financial Officer | 0.03% |
| Shelley Bridarolli | Executive Vice President | 0.02% |
| Charles Harrington | Independent Director | 0.02% |
| Lawrence Jackson | Independent Director | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-07-14 | Andrew Moller | -- | Other Acquisition | +743 | -- |
| 2026-06-29 | James Pelletier | EVP & General Counsel | Sale to Issuer | -409 | $145.00 |
| 2026-05-31 | Alan Feldman | Independent Non-Executive Chairperson | Other Acquisition | +1,232 | -- |
| 2026-05-31 | Lawrence Jackson | Independent Director | Other Acquisition | +1,232 | -- |
| 2026-05-31 | Polly Kawalek | Independent Director | Other Acquisition | +1,964 | -- |
| 2026-05-31 | Barbara Brasier | Independent Director | Other Acquisition | +1,232 | -- |
| 2026-05-31 | Charles Harrington | Independent Director | Other Acquisition | +1,964 | -- |
| 2026-05-31 | Ann Savage | Director | Other Acquisition | +1,232 | -- |
| 2026-05-31 | Svafa Gronfeldt | Director | Other Acquisition | +1,232 | -- |
| 2026-05-31 | Arnar Masson | Director | Other Acquisition | +1,232 | -- |
| 2026-05-31 | Olafur Gudmundsson | Director | Other Acquisition | +1,232 | -- |
| 2026-05-31 | Andrew Moller | -- | Initial Statement of Beneficial | 0 | -- |
| 2026-03-02 | Brian Deck | Chief Executive Officer | Open Market Disposition | -18,634 | $150.51–151.39 |
| 2026-03-02 | Brian Deck | Chief Executive Officer | Intent to Sell (Form 144) | -8,634 | $150.51 |
| 2026-03-01 | Brian Deck | Chief Executive Officer | Intent to Sell (Form 144) | -10,000 | $151.39 |
| 2026-02-26 | Brian Deck | Chief Executive Officer | Sale to Issuer | -2,508 | $154.00 |
| 2026-02-26 | Shelley Bridarolli | Executive Vice President | Sale to Issuer | -247 | $154.00 |
| 2026-02-26 | Matthew Meister | Chief Financial Officer | Sale to Issuer | -476 | $154.00 |
| 2026-02-26 | Robert Petrie | Executive VP & President of Protein | Sale to Issuer | -407 | $154.00 |
| 2026-02-26 | Luiz Rizzolo | Executive VP and President of Diversified Food & Health | Sale to Issuer | -343 | $154.00 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:39:51 · For reference only, not investment advice and not tailored to your situation.